Equities analysts forecast that Concord Medical Services Hldg Ltd (NYSE:CCM) will post earnings per share of ($0.03) for the current fiscal quarter, according to Zacks Investment Research. Zero analysts have provided estimates for Concord Medical Services’ earnings. The firm is scheduled to issue its next quarterly earnings results on Monday, January 1st.

According to Zacks, analysts expect that Concord Medical Services will report full-year earnings of ($0.10) per share for the current fiscal year. For the next year, analysts forecast that the business will report earnings of $0.01 per share. Zacks Investment Research’s earnings per share averages are an average based on a survey of sell-side analysts that that provide coverage for Concord Medical Services.

Separately, Zacks Investment Research upgraded Concord Medical Services from a “sell” rating to a “hold” rating in a research note on Thursday, August 8th.

A hedge fund recently raised its stake in Concord Medical Services stock. Wedbush Securities Inc. raised its holdings in shares of Concord Medical Services Hldg Ltd (NYSE:CCM) by 28.5% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 21,432 shares of the company’s stock after purchasing an additional 4,757 shares during the period. Wedbush Securities Inc.’s holdings in Concord Medical Services were worth $60,000 at the end of the most recent quarter. 1.79% of the stock is currently owned by institutional investors.

CCM traded down $0.11 during trading on Wednesday, hitting $2.57. 4,700 shares of the company’s stock traded hands, compared to its average volume of 9,399. The business’s 50 day moving average is $2.61. The company has a debt-to-equity ratio of 0.90, a current ratio of 1.41 and a quick ratio of 1.41. Concord Medical Services has a 12-month low of $1.85 and a 12-month high of $3.84. The firm has a market cap of $111.02 million, a PE ratio of -2.14 and a beta of -0.16.

About Concord Medical Services

Concord Medical Services Holdings Limited, through its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People's Republic of China. The company's services comprise linear accelerators external beam radiotherapy, gamma knife radiosurgery, head gamma knife systems, body gamma knife systems, CyberKnife robotic radiosurgery system, proton beam therapy systems, and diagnostic imaging services.

Further Reading: The risks of owning bonds

Get a free copy of the Zacks research report on Concord Medical Services (CCM)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Concord Medical Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Concord Medical Services and related companies with MarketBeat.com's FREE daily email newsletter.